CVE-2020-27260
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7…
Does this matter?
Lower severity and a low EPSS score (0.44%). Track it; it rarely justifies an emergency change on its own.
Description
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.
- CVSS 3.1
- 5.3 MEDIUMCVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
- EPSS
- 0.44% probability · 38th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-74
- Affected
- innokasmedical/vital signs monitor vc150 firmware
- Source
- ics-cert@hq.dhs.gov
EPSS 0.4% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://us-cert.cisa.gov/ics/advisories/icsma-21-007-01Third Party Advisory, US Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-21-007-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.